BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22759760)

  • 21. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
    Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
    N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer.
    Paganini HR; Aguirre C; Puppa G; Garbini C; Ruiz Guiñazú J; Ensinck G; Vrátnica C; Flynn L; Iacono M; Zubizarreta P;
    Cancer; 2007 Jun; 109(12):2572-9. PubMed ID: 17492687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic use before chemotherapy: a risk factor for developing neutropenic colitis in children with leukemia.
    Reyna-Figueroa J; Garcia-Beristain JC; Galindo-Delgado P; Limon-Rojas AE; Madrid-Marina V
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):121-7. PubMed ID: 25089604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
    Ammann RA; Hirt A; Lüthy AR; Aebi C
    Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Empirical antimicrobial therapy of infection and fever episodes in children and adolescents with neutropenia caused by cytotoxic chemotherapy].
    Fink FM; Frischhut-Schiffer EM; Ausserer B; Allerberger F; Guggenbichler JP
    Padiatr Padol; 1989; 24(1):33-42. PubMed ID: 2717190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma.
    Lyman GH; Poniewierski MS; Culakova E
    Expert Opin Drug Saf; 2016; 15(4):483-92. PubMed ID: 26809103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
    Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
    Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
    Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
    Rondinelli PI; Ribeiro Kde C; de Camargo B
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia.
    Latiff Z; Zulkifli SZ; Jamal R
    Malays J Pathol; 2002 Dec; 24(2):83-9. PubMed ID: 12887165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia.
    Hitoglou-Hatzi S; Hatzistilianou M; Gougoustamou D; Rekliti A; Agguridaki Ch; Athanassiadou F; Frydas S; Kotsis A; Catriu D
    Clin Exp Med; 2005 Jul; 5(2):60-5. PubMed ID: 16096855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [High risk febrile neutropenia in acute leukemia. The experience of a public hospital. National Program of Antineoplastic Drugs in Adult, Hospital del Salvador, 1991-2001].
    Puga B; Puga I; Cabrera ME; Undurraga MS; Guerra C; Urrejola G; Toro P
    Rev Med Chil; 2003 Sep; 131(9):1023-30. PubMed ID: 14635589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of hematopoietic growth factors G-CSF/GM-CSF in the treatment of neutropenia in children with acute lymphoblastic leukemia and non-Hodgkin's lymphomas].
    Nowak K; Pekacka K; Trelińska J; Stolarska M; Bodalski J
    Wiad Lek; 1998; 51 Suppl 4():237-42. PubMed ID: 10731975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.